Valuation: OPC Pharmaceutical

Market Cap 1,41300Cr 5.49Cr 4.98Cr 4.6Cr 4.15Cr 7.83Cr 517.9Cr 8.1Cr 55Cr 22Cr 276.65Cr 21Cr 20Cr 878.17Cr P/E 2024
17.6x
P/E 2025 15.6x
Enterprise Value 1,09300Cr 4.25Cr 3.85Cr 3.56Cr 3.22Cr 6.06Cr 400.88Cr 6.27Cr 43Cr 17Cr 214.14Cr 16Cr 16Cr 679.75Cr EV / Sales 2024
1.4x
EV / Sales 2025 1.08x
Free-Float
59.86%
Yield 2024 *
-
Yield 2025 3.33%
02/11 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
11/09 OPC Pharmaceutical Joint Stock Company Announces Change In Certificate Of Business Registration CI
17/08 Opc Pharmaceutical Joint Stock Company Terminates Operations of Tien Giang Branch CI
31/07 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
20/07 Opc Pharmaceutical Joint Stock Company Receives Tax Authority Fine of VND 22,000,000 for Late Submission of Natural Resource Tax Returns CI
07/07 OPC Pharmaceutical Joint Stock Company Announces Committee Changes, Effective July 2, 2026 CI
26/06 OPC Pharmaceutical Joint Stock Company Receives Approval for the Termination of Operations of Nghe an Branch CI
29/04 Opc Pharmaceutical Joint Stock Company Announces Board Changes, Effective April 25, 2026 CI
28/04 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
06/04 OPC Pharmaceutical Joint Stock Company announces Annual dividend, payable on July 20, 2026 CI
30/01 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
26/25/26 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
24/25/24 OPC Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
1 day-0.79%
1 week-2.08%
Current month-5.99%
1 month-5.51%
3 months-11.08%
6 months-5.35%
Current year-8.11%
1 week 18,850
Extreme 18850.00000000
19,350
1 month 18,850
Extreme 18850.00000000
20,050
Current year 18,250
Extreme 18250
22,600
1 year 18,034.19
Extreme 18034.188034
22,600
3 years 17,948.72
Extreme 17948.717948
23,076.92
5 years 17,948.72
Extreme 17948.717948
26,239.32
10 years 13,121.96
Extreme 13121.963329
26,239.32
Manager TitleAgeSince
Chief Executive Officer 60 14/07/2021
Chief Administrative Officer - -
Chief Tech/Sci/R&D Officer 56 02/05/2011
Director TitleAgeSince
Chairman 70 01/04/2011
Chairman - 22/10/2021
Director/Board Member 51 22/10/2021
Date Insider Type Main position Quantity % Market Cap. Importance
05/08/24 Sell

Controller/Auditor

2,00,000 0.3123%
07/03/24 Buy 85,84,829 13.4031%
18/12/23 Sell 1,11,34,200 17.3834%
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-2.08%+0.48%-3.69% 5.49Cr
+1.26%+6.61%+40.79%+145.27% 1,28600Cr
+0.79%+3.45%+45.84%+92.04% 69TCr
+0.20%+1.28%+26.97%+114.41% 52TCr
-0.44%+3.69%+41.45%+70.04% 39TCr
+0.55%+0.70%+59.02%+45.79% 36TCr
-0.12%+0.74%+28.39%+60.32% 30TCr
+0.37%+0.37%+3.33%+38.57% 29TCr
-0.30%+1.14%+38.29%+70.56% 25TCr
+0.08%+0.71%+34.44%+123.99% 21TCr
Average +0.16%+1.66%+31.90%+75.73% 43TCr
Weighted average by Cap. +0.54%+3.26%+37.70%+99.28%

Financials

2024 2025
Net sales 97TCr 3.77Cr 3.41Cr 3.16Cr 2.85Cr 5.37Cr 355.1Cr 5.56Cr 38Cr 15Cr 189.69Cr 14Cr 14Cr 602.13Cr 1,12300Cr 4.37Cr 3.96Cr 3.66Cr 3.3Cr 6.22Cr 411.71Cr 6.44Cr 44Cr 17Cr 219.93Cr 16Cr 16Cr 698.12Cr
Net income 11TCr 41.63L 37.72L 34.89L 31.48L 59.33L 39Cr 61.42L 4.19Cr 1.66Cr 21Cr 1.56Cr 1.53Cr 67Cr 12TCr 45.06L 40.83L 37.77L 34.08L 64.22L 42Cr 66.48L 4.54Cr 1.8Cr 23Cr 1.69Cr 1.66Cr 72Cr
Net Debt -25TCr -96.15L -87.13L -80.59L -72.72L -1.37Cr -91Cr -1.42Cr -9.68Cr -3.84Cr -48Cr -3.61Cr -3.53Cr -153.73Cr -32TCr -1.24Cr -1.12Cr -1.04Cr -93.85L -1.77Cr -117.02Cr -1.83Cr -12Cr -4.95Cr -63Cr -4.66Cr -4.56Cr -198.42Cr
Projected Income Statement - Annual - OPC Pharmaceutical
Logo OPC Pharmaceutical
OPC Pharmaceutical Joint-Stock Company (OPC) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures and markets drugs and other medical products from natural pharmaceutical materials which are cultivated and processed at the facilities of the Company. It is also involved in the production and wholesale trading of pharmaceutical chemicals and supplies, as well as functional food. Moreover, the Company is involved in wine distillery and bottled water manufacturing. On June 13, 2014, the Company announced that it has dissolved its joint venture named OPC EXIM Real Estate Joint Stock Company.
Employees
880
Date Price Change Volume
13/26/13 ₫18,850.00 -0.79% 53,402
11/26/11 ₫19,000.00 -1.30% 14,52,571
10/26/10 ₫19,250.00 0.00% 2,700
09/26/09 ₫19,250.00 0.00% 4,100